ROS has long been recognized as a harmful substance, and its excessive accumulation will cause the release of inflammatory factors, enhance the adhesion of inflammatory factors to endothelial cells, and promote apoptosis and even cause cell death (Forrester et al., 2018)
I'd strongly encourage our member companies manufacturers, exporters, and regulatory affairs teams alike to register and be part of these conversations
By shedding light on the intricacies of drug pricing, we can make informed choices, apply pressure for fair pricing practices, and play a more active role in healthcare decisions
Tirzepatide is a dual GLP-1/GIP receptor agonist thats similar to semaglutide
By embedding equity into every stepfrom prescribing to policywe can ensure that no patient is left behind as demand for GLP1 medications continues to rise
Of course, the FDA only considers the United States